Fragmin 10 000 j.m. a.Xa/0,4 ml

Aperçu du produit

About Fragmin 10 000 j.m. a.Xa/0,4 ml

Fragmin 10 000 j.m. a.Xa/0,4 ml is a prescription anticoagulant medication used to prevent and treat blood clots. It is supplied as a prefilled syringe containing 0,4 milliliters of solution. The product is intended for use under medical supervision and is typically administered by injection into the subcutaneous tissue. Fragmin 10 000 j.m. a.Xa/0,4 ml is manufactured by a reputable pharmaceutical company and complies with regulatory standards for safety and efficacy. The formulation is designed to provide a consistent therapeutic effect while minimizing the risk of adverse reactions. Patients receiving Fragmin 10 000 j.m. a.Xa/0,4 ml should follow the dosing schedule prescribed by their healthcare provider and report any unusual symptoms promptly.

Key Benefits & Uses

• Prevents the formation of new blood clots in high-risk patients.
• Reduces the risk of clot extension in patients with deep vein thrombosis.
• Provides a convenient subcutaneous injection option for outpatient care.

Active Ingredient & Action

The active ingredient in Fragmin 10 000 j.m. a.Xa/0,4 ml is a low molecular weight heparin that selectively inhibits factor Xa, a key enzyme in the coagulation cascade. By blocking factor Xa, the medication reduces thrombin generation and stabilizes the clotting process, thereby preventing the development of dangerous clots. The drug’s pharmacokinetic profile allows for predictable anticoagulation with a relatively short half‑life, which facilitates dose adjustments and monitoring.

Important Notes

Fragmin 10 000 j.m. a.Xa/0,4 ml should only be used as directed by a qualified healthcare professional. Patients with a history of heparin-induced thrombocytopenia or severe renal impairment should discuss alternative therapies with their doctor. The medication must be stored at room temperature and protected from light. Before use, patients should inform their clinician of all current medications, allergies, and medical conditions to avoid potential drug interactions and complications.